What are the ACCP recommendations for antithrombotic therapy in holiday heart syndrome (HHS)?

Updated: May 30, 2018
  • Author: Lawrence Rosenthal, MD, PhD, FACC, FHRS; Chief Editor: Jose M Dizon, MD  more...
  • Print
Answer

The ACCP bases its recommendations for antithrombotic therapy in patients with nonvalvular atrial fibrillation (NVAF) on the CHADS2 score, as follows [36] :

  • CHADS 2 score = 0 (low risk): No antithrombotic therapy
  • CHADS 2 score ≥1 (intermediate or high risk): Oral antithrombotic therapy

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!